Catalyst Wire Dossier Catalyst Wire Dossier

Epivir

Lamivudine · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

57 regulatory and trial events tracked for Epivir, covering 2006-06-13 to 2026-08-20. Get the full timeline:

Most recent: EMA Authorised: Epivir (lamivudine) — ViiV Healthcare BV

See pricing